Search for: "U.S. v. Frank"
Results 41 - 60
of 2,759
Sort by Relevance
|
Sort by Date
30 May 2024, 10:36 am
A. v. [read post]
29 May 2024, 9:01 pm
A few weeks ago, the U.S. [read post]
27 May 2024, 2:27 pm
Wainwright, 372 U.S. 335, 83 S. [read post]
24 May 2024, 6:30 am
Posted by the Harvard Law School Forum on Corporate Governance, on Friday, May 24, 2024 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of May 17-23, 2024 Statement by Chair Gensler on Amendments to Regulation S-P Posted by Gary Gensler, U.S. [read post]
24 May 2024, 6:30 am
Posted by the Harvard Law School Forum on Corporate Governance, on Friday, May 24, 2024 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of May 17-23, 2024 Statement by Chair Gensler on Amendments to Regulation S-P Posted by Gary Gensler, U.S. [read post]
22 May 2024, 9:00 pm
On May 16, the U.S. [read post]
17 May 2024, 9:05 pm
In a U.S. [read post]
Blog Post: Practical Guidance Offers Help with Workplace Issues during Mental Health Awareness Month
13 May 2024, 10:00 pm
See Bradford v. [read post]
12 May 2024, 9:01 pm
” The OCC further notes in the letter that it is “committed to preserving the legal framework for preemption established by Congress, including in the Dodd-Frank Wall Street Reform and Consumer Protection Act. [read post]
10 May 2024, 3:27 am
See State v. [read post]
2 May 2024, 9:01 pm
The U.S. [read post]
26 Apr 2024, 12:05 pm
U.S. [read post]
26 Apr 2024, 6:30 am
Schwartz, Sullivan & Cromwell LLP, on Wednesday, April 24, 2024 Tags: Disclosure, Macquarie v. [read post]
26 Apr 2024, 6:30 am
Schwartz, Sullivan & Cromwell LLP, on Wednesday, April 24, 2024 Tags: Disclosure, Macquarie v. [read post]
25 Apr 2024, 4:12 pm
Today the Supreme Court heard oral argument in Trump v. [read post]
22 Apr 2024, 5:00 am
Freed, — U.S. [read post]
19 Apr 2024, 9:27 am
For more information on SEC v. [read post]
16 Apr 2024, 5:29 am
The U.S. [read post]
13 Apr 2024, 3:33 pm
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
12 Apr 2024, 6:30 am
Arnold, Cravath, Swaine & Moore LLP, on Friday, April 5, 2024 Tags: carbon emissions, Climate change, Climate Disclosure, Final Rule, GHG, SEC Practice Points in Response to Activision Posted by Gail Weinstein, Philip Richter, and Warren de Weid, Fried, Frank, Harris, Shriver & Jacobson LLP, on Saturday, April 6, 2024 Tags: Court of Chancery, delaware, DGCL, moelis Order Issuing Stay In the Matter of the Enhancement and Standardization of Climate-Related Disclosures for… [read post]
